Now showing items 1-1 of 1
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the UASAR 2 clinical trial and an Australian community-based series
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)
Background: Molecular indicators of colorectal cancer prognosis have been assessed in several studies, but most analyses have been restricted to a handful of markers. We aimed to identify prognostic biomarkers for colorectal ...